Skip to main content

We earn commissions from the providers listed here. No provider buys a position, a rating, or a listing. The order is set by hand, and we do not claim it is independent of what we earn. Advertising Disclosure

Manytreatments
Manytreatments
BrowseCategoriesCompareMedicationsBy State
TreatmentsWeight LossED TreatmentHair LossTRT
AboutFAQContact
CategoriesCompareMedicationsBy StateWeight LossED TreatmentHair LossTRTHow We Rate

manytreatments

Compare telehealth providers for weight loss, erectile dysfunction, hair loss, TRT, women's health, mental health, and premature ejaculation treatment. Find pricing, reviews, and licensed US doctors in all 50 states.

Trustpilot
Google Safe Browsing verified site

Treatments

  • Weight Loss
  • ED Treatment
  • TRT
  • Hair Loss
  • Women's Health
  • PE Treatment
  • Mental Health
  • View All Treatments →

Top Brands

  • Hims
  • Medvi
  • Ro
  • Shed
  • Eden
  • Sesame Care
  • Maximus
  • Peter MD
  • View All Brands →

Resources

  • Compare Brands
  • Browse by State
  • Medications
  • Tools
  • Guides
  • Cost Guides
  • Statistics & Price Indexes
  • FAQ
  • About Us
  • Contact Us
  • How We Rate
  • Sitemap

Legal

  • Privacy Policy
  • Terms of Service
  • Affiliate Disclosure
  • Medical Disclaimer
  • Editorial Policy
  • Cookie Policy
  • California Privacy Notice (CCPA)
  • Accessibility Statement

Follow Us

  • Medium
  • YouTube
  • LinkedIn
  • Twitter/X
  • Instagram
  • Threads
© 2026 ManyTreatments.com. All rights reserved.Advertising DisclosureWe may earn commissions from affiliate links.

Content is for informational purposes only and is not medical advice. Compounded medications are not FDA-approved for safety, effectiveness, or quality. Medical Disclaimer

  1. Home
  2. States
  3. Connecticut
  4. Weight Loss
Telehealth treatment comparison background
Eric GoldWritten by Eric GoldEditor-in-Chief
Updated onOctober 09, 2026

Weight Loss Telehealth in Connecticut 2026 14 Providers Compared for CT Residents

In Connecticut, you can get a prescription for weight loss medication online without a video visit first. Insurance covers treatment under state parity law.

Fast Approval
Free Shipping
Exclusive Coupons
Online Prescription
Compare weight loss treatment providers in Connecticut

Key Takeaways

Best weight loss telehealth in Connecticut: Ro for insurance coverage, HealthRx or Strut for the lowest price. Connecticut's insurance parity law covers your online weight loss visits the same as in-person appointments. Compounded semaglutide is legally available through licensed 503B pharmacies, with plans starting at $99/month through HealthRx or Strut; Medvi runs $179 for your first month and $299/month after that, and bundles free dietician visits and care coaching. You have 14 weight loss telehealth providers to choose from in the state.

Who This Is For

This is for
  • You prefer async or audio-only check-ins, both permitted under Connecticut telehealth rules.
  • Connecticut adults ready to choose from 14 available weight loss telehealth providers online.
Not for
  • Connecticut requires prescriptions from a licensed in-state provider, so out-of-state-only services won't work here.
  • The FDA-approved labeling for Wegovy and Zepbound covers weight reduction in adults with a BMI of 30 or higher, and in adults with a BMI of 27 or higher who have at least one weight-related condition such as type 2 diabetes or high blood pressure. If you are near either number, ask a licensed provider where you fall before choosing a platform.
  • If you are pregnant or planning a pregnancy, the Wegovy label directs you to stop semaglutide once pregnancy is recognized and two months before a planned pregnancy, so raise it at intake.
  • If you are breastfeeding, ask the provider what the label for the specific medication says, because the labels differ.
  • If you have a history of disordered eating, tell the provider at intake, because it is part of what a prescriber weighs before starting a weight loss medication.
  • If you have had bariatric surgery or are considering it, tell the provider at intake, because it changes what a prescriber will consider.
  • A remote visit cannot include a physical exam or in-office testing. If that matters for your situation, raise it with a licensed provider before choosing a platform.
  • If this is an emergency, call 911 or go to the nearest emergency room. Telehealth is not for emergency care.

These notes are not a medical screening: a licensed provider decides after an intake review whether a treatment is appropriate for you.

User Preferences & Connecticut Availability

TrimRx is the top choice for 25% of users comparing weight loss providers on ManyTreatments in 2026, followed by Ro (16%) and Hers (14%).

16 licensed telehealth providers offer weight loss programs to Connecticut residents. Connecticut requires prescriptions to be written by a licensed in-state provider.

Medical Disclaimer: Content is for informational purposes only - not medical advice. Consult a licensed healthcare provider before any treatment. Learn more

Best Value
1
Ro logo

Wegovy® From $149/mo Plus Membership From $74/mo - Free Insurance Check

  • Full GLP-1 suite: Zepbound®, Wegovy® pill and pen, semaglutide and more
  • Free insurance check shows what your plan covers before you pay
  • Tirzepatide (Zepbound®) averaged up to 20.9% body weight loss in the 72-week SURMOUNT-1 trial; individual results vary
  • On-demand provider coaching and support, 100% online
LegitScript lists Ro as certified, checked on LegitScript's status page September 20, 2026CertifiedSeptember 20, 2026
9.3
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
Most Popular
2
Medvi logo

First Month $179, Then $299/mo With No Membership Fee

  • Doctor-guided compounded GLP-1 care, 100% online. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
  • Free dietician visits and care coaching included with your plan
  • Doctor-formulated plans adjusted as your body responds
  • Fast, discreet shipping to your door
LegitScript lists Medvi as certified, checked on LegitScript's status page September 20, 2026CertifiedSeptember 20, 2026
9.2
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
3
Strut logo

Start for Free - Free MD Visit, Follow-Up Care & Shipping

  • Compounded injectable semaglutide prescribed by U.S.-licensed physicians. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
  • Free online MD visit and free follow-up care included
  • Free shipping - fill through Strut's pharmacy network or your local pharmacy
  • Your Strut doctor manages your dosage increase plan as treatment progresses
Strut displays LegitScript certificate 11142478, checked September 19, 2026Cert. 11142478September 19, 2026
9.4
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
4
Fridays logo

Compounded Semaglutide From $150/mo on Prepaid Plans

  • Compounded semaglutide from $150/mo, tirzepatide from $240/mo on prepaid plans
  • Insurance concierge works to maximize your coverage
  • GLP-1 microdosing option and a custom plan in under 3 minutes
Fridays displays LegitScript certificate 18528873, checked September 19, 2026Cert. 18528873September 19, 2026
9.2
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
5
Sprout Health logo

Compounded Semaglutide From $199/mo - Free 2-Minute Quiz

  • Compounded semaglutide and tirzepatide from $199/mo. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
  • Prescribed by US-licensed clinicians with personalized dosing - no waiting room
  • Ships from a US pharmacy in discreet, refrigerated packaging
9.0
ExcellentScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
6
Eden logo

Start for Just $129 First Month. Same Price Every Dose

  • Compounded semaglutide & tirzepatide custom dosed. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
  • Free consults with US doctors, 24/7 messaging
  • Fast discreet shipping, cancel anytime no contracts
  • Ongoing optimization for your health goals
9.1
ExcellentScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
7
HealthRx logo

Compounded GLP-1 From $99/mo - Full Refund If You Are Not Approved

  • Compounded semaglutide & tirzepatide GLP-1, from $99/mo on the 12-month plan ($133/mo for 3 months)
  • No insurance needed - full refund if a licensed provider doesn't approve you
  • Physician-supervised online intake, and HealthRx displays LegitScript certification seal 50087439, which we checked with LegitScript on September 19, 2026
  • Ships from US pharmacies in 24-48 hours with fast, free delivery
HealthRx displays LegitScript certificate 50087439, checked September 19, 2026Cert. 50087439September 19, 2026
9.1
ExcellentScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
View 7 More Weight Loss Providers
8
Peter MD logo

Starting at $209/mo - $100 Off Your First Month

  • Compounded semaglutide option available. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
  • Board-certified obesity medicine specialists
  • All supplies & shipping included in price
  • No surprise bills - transparent pricing
9.5
ExceptionalScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
9
Skinny.Rx logo

25% Lower Prices on All GLP-1s - Semaglutide From $149.25/mo

  • Compounded injectable semaglutide from $149.25/mo, tirzepatide tablets from $224.25/mo. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
  • FDA-approved Wegovy® and other GLP-1s available, plus daily oral options via membership
  • Clinician-guided care, not just a prescription - ongoing dose adjustments and provider check-ins
  • App with care team support, medication reminders and weight trend tracking
9.0
ExcellentScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
10
Hers logo

FDA-Approved GLP-1s From $149/mo Plus Required $149/mo Membership

  • Oral GLP-1 options from $149/mo, semaglutide from $199/mo
  • Personal plan with ongoing care from day 1 via membership
9.1
ExcellentScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
Our Top Choice
11
TrimRx logo

GLP-1 Weight Loss From $179/mo - Free 2-Minute Assessment

  • Compounded GLP-1 (semaglutide) from $179/mo, GLP-1 + GIP (tirzepatide) from $259/mo
  • Brand-name Ozempic®, Mounjaro®, Zepbound® and Wegovy® also available
  • Free 2-minute qualification quiz and FREE doctor consultation - no cost, no obligation
  • Free tracked shipping straight to your door after approval
TrimRx displays LegitScript certificate 31417191, checked September 19, 2026Cert. 31417191September 19, 2026
9.4
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
12
Hims logo

FDA-Approved GLP-1s From $149/mo Plus Required $149/mo Membership

  • Oral GLP-1 options from $149/mo, semaglutide from $199/mo
  • Personal plan with on-demand care from day 1 via membership
9.4
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
13
Shed logo

Semaglutide From $159/mo - 120-Day Refund If You Don't Lose 5%

  • Compounded semaglutide as low as $159/mo, tirzepatide from $239/mo. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
  • 120-day money-back guarantee - refund if you don't lose 5%, per Shed's terms
  • 100% online visit and checkout - prescription shipped straight to your door
  • Health coaching support included alongside your GLP-1 program
Shed displays LegitScript certificate 44256860, checked September 19, 2026Cert. 44256860September 19, 2026
9.0
ExcellentScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
14
Sesame Care logo

Wegovy Pill From $149/mo Plus Care Plans From $59/mo - Same-Day Visits

  • Cash-pay GLP-1 medications as low as $149/mo, insurance accepted for weight loss meds
  • Ongoing video visits, dedicated provider, labs and messaging from $59/mo
  • 1M+ patients treated with 95% patient satisfaction
9.1
ExcellentScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
See PricingRead full review
Our Top Choice
TrimRx logo

GLP-1 Weight Loss From $179/mo - Free 2-Minute Assessment

  • Compounded GLP-1 (semaglutide) from $179/mo, GLP-1 + GIP (tirzepatide) from $259/mo
  • Brand-name Ozempic®, Mounjaro®, Zepbound® and Wegovy® also available
  • Free 2-minute qualification quiz and FREE doctor consultation - no cost, no obligation
  • Free tracked shipping straight to your door after approval
9.4
★★★★★
Visit TrimRx

About This Comparison

Our Editorial Standards

This weight loss provider comparison is independently researched by our editorial team. We compare telehealth services based on publicly available information including pricing, available treatments, and service areas. Our ratings are editorial judgments, not tallies of reviews.

Independent Research: We do not accept payment for rankings or favorable reviews
Affiliate Disclosure: We may earn commissions from qualifying purchases at no extra cost to you
Regular Updates: Content is reviewed and updated monthly for accuracy
Licensed Providers Only: All listed services employ US-licensed healthcare providers

Not Medical Advice: This comparison is for informational purposes only. We are not healthcare providers. Always consult with a licensed physician before starting any treatment. Read our full medical disclaimer and editorial policy.

Independent ResearchNo paid placements
Fact-Checked InformationVerified against official sources
Regularly UpdatedLast updated October 9, 2026
Licensed Providers OnlyAll listed services are US-licensed

Weight Loss Telehealth in Connecticut 2026: 14 Providers Compared for CT Residents

Eric GoldWritten by Eric GoldEditor-in-Chief
18 min readUpdated October 9, 2026

Table of Contents

14 weight loss telehealth providers serve Connecticut in 2026. Compare Ro, Medvi, Wegovy access, compounded semaglutide pricing, and CT insurance coverage rules.

Which Weight Loss Providers Are Actually Available in Connecticut

14 weight loss telehealth providers serve Connecticut residents in 2026. That is a strong number compared to many states, and it gives you real options across price points, medication types, and care models. Clinic Secret, Nurx, and UrWay Health are not among the 14 platforms compared on this page, so check clinicsecret.com, nurx.com, or urwayhealth.com directly if you want to look into them.
The 14 that do serve Connecticut are Ro, Medvi, Strut, Sprout Health, Fridays, Eden, HealthRx, Peter MD, Skinny.Rx, Hers, Hims, TrimRx, Shed, and Sesame Care. That list covers every major treatment path: brand-name GLP-1s like Wegovy and Ozempic, compounded semaglutide and tirzepatide, older medications like phentermine and metformin, and behavioral coaching programs layered on top of medication. Connecticut residents are not forced into a narrow menu the way residents in some smaller states are.
The right starting point depends heavily on what you actually want. If cost is the primary filter, HealthRx or Strut at $99 per month is the answer, not Medvi. If you have insurance and want to use it for brand-name Wegovy, Ro is the name to know. If you are brand new to GLP-1 medications and want hand-holding through the process, Sprout Health is specifically positioned for that. The sections below break each scenario down in detail so you are not guessing.

Connecticut's Insurance Parity Law and What It Means for Your Weight Loss Costs

Connecticut has full telehealth insurance parity, meaning your insurance company is legally required to reimburse an online weight loss consultation at the same rate as an in-person visit. This is not the case in every state. If you are in Connecticut and have commercial insurance, you should not be paying out-of-pocket for your provider visit when you can find a platform that bills your insurer. That visit cost, which can run $75 to $150 on cash-pay platforms, disappears when you use a parity-compliant service.
Fridays is another insurance-friendly option in Connecticut. Its insurance concierge team works directly with you on coverage questions for weight loss medication, so you are not left guessing what your plan will or will not pay for. If your insurer covers Wegovy or Zepbound, Fridays' concierge team can help you work through what that means for your plan.
Ro is worth mentioning here separately because it goes one step further than most platforms. Ro actively helps you navigate brand-name GLP-1 access, meaning it will work with your insurance on prior auth for Wegovy or Ozempic, and it also has a cash-pay compounded semaglutide path if your insurer says no. That dual-track setup is genuinely useful in Connecticut, where insurer decisions on GLP-1 coverage vary significantly between Anthem, Cigna, Aetna, and the various employer-sponsored plans common in the Hartford and Fairfield County corridors.
Connecticut also has broader Medicaid coverage for preventive women's health care than many states. If you are on HUSKY Health and meet clinical thresholds for weight loss treatment, it is worth a direct call to check your specific plan's formulary before assuming you will need to pay cash for everything.

The Cheapest Way to Get Weight Loss Medication in Connecticut Right Now

If you are paying out of pocket and want to keep costs as low as possible, HealthRx and Strut are your cheapest starting points in Connecticut, both from $99 per month for compounded semaglutide. Eden follows at $129 per month and Fridays at $150, while Ro is much higher at $223 per month once its membership and its medication are counted together. Medvi sits at the top of the price ladder at $299 per month for refills, after a $179 first month, but its plan bundles free dietician visits and ongoing care coaching into that price, which the cheaper options do not include. For context, brand-name Wegovy without insurance runs over $1,300 per month at Connecticut retail pharmacies. Compounded semaglutide contains semaglutide, the active ingredient in Wegovy, at a fraction of the cost, dispensed through a licensed 503B pharmacy. It is not FDA-approved and is not reviewed by the FDA for safety, effectiveness, or quality.
Skinny.Rx is next in the budget tier, at $149.25 per month for compounded semaglutide, still noticeably cheaper than Medvi. It offers straightforward monthly pricing with no frills and no long onboarding process. If you want the free dietician visits and care coaching Medvi bundles into its higher price, Medvi is the option built for that, not the cheapest one.
Sesame Care takes a different approach that can also work out cheap depending on how you use it. It operates as a pay-per-visit marketplace rather than a subscription, so if you only need one or two consultations to get a prescription written and then fill it at a local Connecticut pharmacy yourself, you are not locked into a monthly platform fee. The trade-off is that Sesame does not manage medication supply for you the way Medvi or Ro does, so you need to be more hands-on.

Compounded Semaglutide and Tirzepatide in Connecticut: What's Legal and What to Expect

Compounded GLP-1 medications are available in Connecticut in 2026 through licensed 503B outsourcing facilities, which are FDA-regulated compounding pharmacies that produce medications at scale. This is the legal framework that allows platforms like Medvi, Sprout Health, Shed, and others to ship compounded semaglutide and tirzepatide to Connecticut residents. The key phrase is 503B licensed. If a platform cannot tell you which 503B facility fills their prescriptions, that is a red flag.
The reason compounded versions exist and remain available is that Wegovy and Ozempic have experienced supply constraints, and FDA policy allows compounding to continue as a practical alternative during those periods. For Connecticut residents, this means you can realistically access semaglutide-based weight loss treatment at $149 to $199 per month rather than the brand-name price, and the clinical effect is the same active compound at the same doses.
Compounded tirzepatide is also available in Connecticut. Tirzepatide is the active ingredient in Zepbound and Mounjaro. Sprout Health and Shed both offer tirzepatide-based compounded programs for Connecticut residents. The pricing is typically slightly higher than semaglutide, running $200 to $350 per month depending on dose and platform. If you have already tried semaglutide without adequate results, tirzepatide is a clinically meaningful step up and worth discussing with a provider.
One thing to set expectations on: compounded medications are not interchangeable with brand-name products at your Connecticut pharmacy. You receive them directly through the platform or their affiliated mail pharmacy. You do not take a prescription to CVS or Walgreens and fill compounded semaglutide there. The entire supply chain runs through the telehealth platform and the pharmacy it works with.

Can You Get Phentermine Online in Connecticut?

This is one of the most common searches Connecticut residents run, and the answer is yes, but with conditions. Phentermine is a Schedule IV controlled substance, which means federal regulations require a legitimate prescriber-patient relationship before any controlled substance can be prescribed. In Connecticut, telehealth providers can prescribe phentermine, but they must conduct a thorough clinical evaluation first. You cannot get a phentermine prescription in three clicks on a bare-bones intake form.
Platforms that offer phentermine as part of their Connecticut weight loss programs include Sesame Care and Peter MD. Peter MD in particular covers weight loss alongside men's health and uses physician-led protocols that include non-GLP-1 options like phentermine and metformin. If you prefer phentermine over injectable medications, or if you are not clinically eligible for GLP-1s, these platforms are the ones to look at.
Metformin and bupropion-naltrexone are also available through Connecticut telehealth providers without the controlled substance restrictions. These are oral medications with different mechanisms from GLP-1 injectables. They produce more modest weight loss results on average, but they are often a better fit if you have contraindications to GLP-1s or want to start with something non-injectable.

The Highest-Rated Weight Loss Platforms Serving Connecticut in 2026

Hims and Strut both carry a 9.4 rating, among the highest for weight loss platforms available in Connecticut (only Peter MD's 9.5 rates higher), though Hims is the more relevant one for pure weight loss since Strut focuses primarily on hair loss and men's health compounding. Hims has a well-built mobile experience, affordable pricing, and a weight loss track that includes compounded semaglutide with ongoing provider check-ins. For Connecticut residents who want a polished digital experience and do not need intensive clinical hand-holding, Hims is a strong pick.
Ro sits at 9.3. Where Ro earns its score is in the breadth of its clinical approach. It does not just write a prescription and disappear. Ro's platform includes ongoing care coordination, insurance navigation for brand-name GLP-1s, and a structured program that monitors your progress. For Connecticut residents who have insurance that might cover Wegovy, Ro is probably the most capable platform at actually getting that coverage sorted out.
Medvi also holds a 9.2 rating and is the Connecticut platform carrying the Most Popular flag, a signal about uptake rather than about price. At $299/month for refills after a $179 first month, it is the most expensive platform on this list (HealthRx and Strut start at $99), but it bundles free dietician visits and ongoing care coaching into that price, and its rating confirms the clinical quality is real. If you are uninsured or your insurer does not cover GLP-1s and want that level of support, Medvi is worth the higher price.
Hers is worth calling out specifically for Connecticut women. It holds a 9.1 rating and covers weight loss alongside birth control, hair loss, and mental health in a single platform. Connecticut's full insurance parity and strong Medicaid access for women's preventive care makes Hers particularly practical here. If you want a single platform that can handle multiple health needs under one login and one potential insurance billing relationship, Hers is built for exactly that.

Getting Wegovy or Ozempic in Connecticut: What the Brand-Name Path Actually Looks Like

Brand-name Wegovy and Ozempic are available in Connecticut, but the access path is genuinely complicated by insurance requirements and prior authorization rules. No telehealth platform can just write you a Wegovy prescription and have it show up at your door without a prior auth from your insurer if you want it covered. The prior auth process requires documentation of your BMI, any weight-related comorbidities like type 2 diabetes, hypertension, or sleep apnea, and often proof that you have tried other interventions first.
The clinical threshold for GLP-1 eligibility in Connecticut follows standard guidelines: a BMI of 30 or higher without comorbidities, or a BMI of 27 or higher with at least one weight-related condition. Most Connecticut residents who are genuinely interested in Wegovy will qualify on the BMI criterion alone, but the insurance approval is a separate question from clinical eligibility.
Ro is the Connecticut-available platform most experienced at managing the insurance side of brand-name GLP-1 access. If you have type 2 diabetes and your provider is prescribing Ozempic for that indication, your coverage odds improve substantially over a straight Wegovy request for weight loss alone. Ro handles both cases, including non-diabetic patients seeking Wegovy, and will pursue the prior auth process on your behalf.

What Makes Weight Loss Telehealth Different in Connecticut vs. Other States

Connecticut is one of the more favorable states for telehealth weight loss treatment, and several specific factors work in your favor. Full insurance parity has been in place long enough that most major insurers operating in Connecticut, including Anthem BlueCross BlueShield of Connecticut, Cigna, and Aetna, have established telehealth billing processes. You are not fighting for coverage on a procedural technicality; the billing infrastructure exists and works.
Connecticut also has a relatively high density of employed residents with employer-sponsored insurance, particularly in Fairfield County and the Hartford metro. That employer coverage often includes GLP-1 benefits that have expanded significantly since 2024 as large employers added weight management coverage to compete for talent. If you have employer insurance, it is worth checking your benefits portal specifically for weight management or GLP-1 coverage before assuming you need to use a cash-pay platform.
The state's proximity to major medical centers like Yale New Haven Hospital and Hartford HealthCare also means Connecticut's telehealth providers are operating in a market where patients are health-literate and providers have to compete on clinical quality, not just price. That competitive pressure tends to keep standards higher. You are less likely to encounter a Connecticut-serving platform that operates as a pure prescription mill compared to states with less regulatory oversight.
One practical consideration specific to Connecticut is that many residents commute to New York for work. If you spend significant time in New York, confirm that any platform you choose is licensed in both states, or that Connecticut-based prescriptions will remain valid for your mail pharmacy deliveries regardless of where you physically are during the week. All 14 platforms listed here are licensed in Connecticut; multi-state coverage varies and is worth confirming if you travel regularly.

Matching the Right Connecticut Provider to Your Specific Situation

If you are uninsured and want the lowest possible monthly cost, HealthRx and Strut lead at $99 per month, with Eden at $129 and Fridays at $150 the next steps up. If you want doctor-guided care with free dietician visits and coaching bundled in and don't mind paying more for it, Medvi is $179 for your first month and $299 per month after that for compounded semaglutide with clinical support included.
If you have insurance and want to use it, begin with Fridays or Ro. Fridays works best if you want its insurance concierge team helping you work through coverage questions for weight loss medication. Ro is the better choice if your goal is specifically brand-name Wegovy and you want a platform experienced at fighting prior auth denials and walking you through the appeals process when needed.
If you want behavioral support layered on top of medication, Shed combines compounded GLP-1 medications with structured behavioral coaching. Sprout Health similarly offers nutritionist support alongside its medication program. Both serve Connecticut and are worth considering if past weight loss attempts failed partly because the clinical piece was solved but the behavioral piece was not addressed.
If you are a Connecticut woman who wants a platform covering multiple health areas, Hers is the obvious choice. Weight loss, birth control, mental health, and hair loss all in one place, billed through a single telehealth relationship that Connecticut's parity law supports. For Connecticut men wanting similar multi-condition coverage, Hims or Peter MD covers ED, hair loss, mental health, and weight loss under one platform.

Frequently Asked Questions

How many weight loss telehealth providers are available in Connecticut in 2026?

Fourteen weight loss telehealth providers are compared on this page for Connecticut. They are Ro, Medvi, Strut, Sprout Health, Fridays, Eden, HealthRx, Peter MD, Skinny.Rx, Hers, Hims, TrimRx, Shed, and Sesame Care. Clinic Secret, Nurx, and UrWay Health are not among them, so check clinicsecret.com, nurx.com, or urwayhealth.com directly if you want to look into them. The 14 platforms compared here cover every major treatment path from compounded semaglutide at $149 per month to insurance-navigated brand-name Wegovy to behavioral coaching programs layered on top of medication.

Is Ro available in Connecticut for Wegovy prescriptions?

Yes, Ro is fully available in Connecticut and is one of the stronger options here specifically because of how it handles brand-name GLP-1 access. Ro works with Connecticut insurance plans on prior authorization for Wegovy and Ozempic, which is the main barrier most residents face. If your insurer denies coverage, Ro also offers a compounded semaglutide path so you are not left without medication while appealing. For Connecticut residents with Anthem, Cigna, or Aetna plans that may cover GLP-1s, Ro's dual-track approach, insurance first, compounded as backup, is genuinely practical. Ro holds a 9.3 rating and is among the most capable platforms at navigating the brand-name access process in Connecticut.

What is the cheapest weight loss medication program available in Connecticut?

HealthRx and Strut are the lowest-cost options for Connecticut residents paying out of pocket, both starting at $99 per month for compounded semaglutide. Eden follows at $129, Skinny.Rx at $149.25, and Fridays at $150, with Ro higher again at $223 once its membership and its medication are counted together. Medvi is priced highest at $299 per month for refills, after a $179 first month, but that price bundles free dietician visits and ongoing care coaching, which the cheaper options do not include. For context, brand-name Wegovy at Connecticut retail pharmacies costs over $1,300 per month without insurance. Compounded semaglutide contains semaglutide, the active ingredient in Wegovy, at a fraction of the cost, dispensed through an FDA-registered 503B pharmacy; it is not FDA-approved.

Can I get semaglutide through telehealth in Connecticut without insurance?

Yes. Compounded semaglutide is available in Connecticut through multiple telehealth platforms without insurance. Medvi, Skinny.Rx, Shed, Sprout Health, and Hims all offer compounded semaglutide to Connecticut residents on a cash-pay basis. The standard price range is $149 to $299 per month depending on the platform and dose tier. Connecticut's regulatory environment permits compounded GLP-1 prescriptions through licensed 503B outsourcing facilities. You do not need a referral from a primary care provider. You complete an online intake, a licensed Connecticut provider reviews it, and medication ships directly to your Connecticut address if you qualify clinically.

Does Connecticut insurance cover online weight loss visits the same as in-person?

Yes. Connecticut has full telehealth insurance parity, which means your insurer is legally required to reimburse online weight loss consultations at the same rate as in-person visits. This applies to commercial insurance plans regulated in Connecticut. Major Connecticut insurers including Anthem BlueCross BlueShield of Connecticut, Cigna, and Aetna have established telehealth billing processes that support this. Practically, this means if you use Fridays or Ro and have Connecticut insurance, your provider visit cost may be partially or fully covered by your plan. The medication cost is a separate question governed by your pharmacy benefits, but the visit itself should not be an out-of-pocket expense if your plan covers primary care.

Can I get phentermine prescribed online in Connecticut?

Yes, phentermine can be prescribed through telehealth in Connecticut, but it requires a proper clinical evaluation because it is a Schedule IV controlled substance. You cannot get it through a bare-bones online intake form. Platforms that include phentermine as part of their Connecticut weight loss programs include Sesame Care and Peter MD. Each requires a thorough review of your medical history, current medications, and weight history before a provider will prescribe a controlled substance. If you are looking for a non-injectable oral alternative to GLP-1 medications, phentermine is a reasonable clinical option for some Connecticut patients, and metformin or bupropion-naltrexone are available with fewer prescribing restrictions through most of the same platforms.

Is compounded tirzepatide available in Connecticut?

Yes, compounded tirzepatide is available in Connecticut through licensed 503B pharmacies that partner with telehealth platforms. Sprout Health and Shed both offer tirzepatide-based programs for Connecticut residents. Tirzepatide is the active ingredient in Zepbound and Mounjaro, and compounded versions are legally available under the same FDA framework that permits compounded semaglutide during brand-name supply constraints. Pricing for compounded tirzepatide runs slightly higher than semaglutide, typically in the $200 to $350 per month range depending on dose and platform. Clinically, tirzepatide targets two hormonal pathways instead of one, which produces meaningfully stronger average weight loss results in trial data. It is a legitimate option for Connecticut patients who have tried semaglutide without sufficient results.

Which Connecticut weight loss telehealth platform is best for women?

Hers is the strongest single-platform option for Connecticut women. It covers weight loss alongside birth control, hair loss, and mental health, and Connecticut's full insurance parity law means multiple services can be billed to your insurer through one telehealth relationship. Hers holds a 9.1 rating. Connecticut's broader Medicaid coverage for women's preventive care through HUSKY Health may also apply to Hers-managed services depending on your specific plan. For women who want weight loss only without multi-condition coverage, Medvi is a strong Connecticut option at $179 for your first month and $299 per month after that, with free dietician visits and care coaching included, and a 9.2 rating.

How do I qualify for weight loss medication through a Connecticut telehealth provider?

The standard clinical threshold for GLP-1 weight loss medications in Connecticut follows national guidelines: a BMI of 30 or higher qualifies without any additional conditions, and a BMI of 27 or higher qualifies with at least one weight-related comorbidity such as type 2 diabetes, hypertension, high cholesterol, or sleep apnea. Most telehealth platforms serving Connecticut use an online intake form where you enter your height, weight, and health history. A licensed Connecticut provider reviews that intake and determines eligibility. If you qualify clinically, the next step is either a prescription being written directly, or an insurance prior authorization process if you are seeking brand-name Wegovy or Ozempic rather than compounded medication.

What is the difference between Henry Meds and Ro for Connecticut residents seeking Ozempic?

Henry Meds is not one of the platforms compared on this page, so Ro is your Connecticut option here for insurance-navigated GLP-1 access, whether you have a type 2 diabetes diagnosis and are seeking Ozempic or you are pursuing Wegovy for weight loss alone. Ro pursues insurance prior authorization for brand-name GLP-1s and offers a compounded semaglutide backup if your insurer denies coverage. Ro holds a 9.3 rating.

Sources & References

Our comparisons are informed by official sources and regulatory guidelines. We encourage you to verify information with authoritative sources.

  • America's Health Rankings - Obesity in ConnecticutConnecticut adult obesity prevalence data from the CDC Behavioral Risk Factor Surveillance System.
  • NIDDK - Weight ManagementNIDDK evidence-based guidance on weight management: BMI thresholds, GLP-1 medications, and health risks of obesity.
  • CCHP Telehealth Policy - ConnecticutConnecticut state telehealth laws, online prescribing rules, and insurance reimbursement policies maintained by the Center for Connected Health Policy.
  • NIMH - Mental Illness StatisticsNIMH data: 1 in 5 U.S. adults experience mental illness annually. National prevalence by condition, age, and demographic.
  • CDC - Adult Obesity FactsCDC data: over 40% of U.S. adults have obesity, with $173 billion in annual medical costs. National prevalence and demographic breakdowns.
  • America's Health Rankings - Diabetes in ConnecticutConnecticut diabetes prevalence among adults, sourced from CDC BRFSS data.
  • America's Health Rankings - Cardiovascular Health in ConnecticutConnecticut cardiovascular disease prevalence, including heart attack, stroke, and coronary heart disease.

Editorial Note: Researched and edited by our editorial team. AI tools assist with initial research and drafting; all content is fact-checked and edited by humans before publication. Learn more about our editorial standards

TrimRx logo

GLP-1 Weight Loss From $179/mo - Free 2-Minute Assessment

  • Compounded GLP-1 (semaglutide) from $179/mo, GLP-1 + GIP (tirzepatide) from $259/mo
  • Brand-name Ozempic®, Mounjaro®, Zepbound® and Wegovy® also available
  • Free 2-minute qualification quiz and FREE doctor consultation - no cost, no obligation
  • Free tracked shipping straight to your door after approval
9.4
★★★★★
Visit TrimRx

Compare Top Weight Loss Providers

See how the top weight loss providers in Connecticut stack up against each other:

Ro vs MedviRo vs StrutRo vs FridaysView All Comparisons →

More Telehealth Options in Connecticut

Explore other telehealth treatments available in Connecticut:

Erectile Dysfunction in ConnecticutHair Loss in ConnecticutWomens Health in ConnecticutPremature Ejaculation in ConnecticutMental Health in ConnecticutWeight Loss NationwideGLP-1 Price Index 2026How to Get Ozempic Without Insurance (2026 Guide)All Connecticut TreatmentsBrowse All States →
Eric Gold
Eric GoldEditor-in-Chief

Eric Gold is a writer and editor with a background in digital media and consumer research. He has spent the last several years covering the health and wellness industry, with a particular focus on telehealth services and direct-to-consumer healthcare. Eric believes that access to clear, unbiased information should not require a medical degree. When he is not reviewing telehealth platforms, he enjoys hiking, cooking, and following the stock market a little too closely.

Medical Disclaimer: The information provided on this page is for informational purposes only and is not intended as a substitute for advice from your physician or other healthcare professional. Telehealth regulations in Connecticut may change. Always verify requirements with your chosen provider. Read our full medical disclaimer.

Regulatory noticeRegulatory note (verified October 8, 2026): On February 20, 2026 the FDA issued MEDVi, LLC a warning letter (MARCS-CMS 721455) citing misbranding under sections 502(a) and 502(bb) of the FD&C Act. Reviewing medvi.io in December 2025, the FDA said labels bearing "MEDVi" implied MEDVi compounds the drugs when it does not, and that site copy presenting the compounded drug as having the same active ingredient as Wegovy and Ozempic, and as Mounjaro and Zepbound, implied an FDA approval compounded drugs do not have. The letter adds that introducing or delivering the products it identifies into interstate commerce is a prohibited act under section 301(a), that receiving them in interstate commerce and delivering or offering to deliver them also violates section 301(c), and that a compounded drug product must meet the conditions of section 503A or 503B of the FD&C Act to be exempt from certain requirements, including the new drug approval requirements. When we checked FDA's warning letter index for MEDVi, LLC on October 8, 2026 it showed no response letter and no close-out letter entered against it, so the letter is not closed out on the public record. MEDVi states medvi.io is affiliate-operated rather than company-operated; we could not verify that, and the letter is addressed to MEDVi, LLC. Read the FDA letter

Regulatory noticeRegulatory note (verified October 8, 2026): The FDA reviewed struthealth.com in December 2025 and, on February 20, 2026, issued Strut Health, LLC a warning letter, MARCS-CMS 721448. It raises two separate problems. Pictured product labels carry the "Strut" name, which the agency said represents Strut as the compounder of the semaglutide and tirzepatide products when it is not. The letter also quotes three claims from the site, among them "Generic Zepbound, Mounjaro", along with site copy naming semaglutide and tirzepatide as the active ingredient in the brand medications. Because compounded drugs hold no FDA approval, the FDA said wording of that kind implies one, and it cited misbranding under sections 502(a) and 502(bb) of the FD&C Act. The letter adds that introducing or delivering the products it identifies into interstate commerce is a prohibited act under section 301(a), that receiving them in interstate commerce and delivering or offering to deliver them also violates section 301(c), and that a compounded drug product must meet the conditions of section 503A or 503B of the FD&C Act to be exempt from certain requirements, including the new drug approval requirements. When we checked FDA's warning letter index for Strut Health, LLC on October 8, 2026 it showed no response letter and no close-out letter, so we treat the matter as open. Read the FDA letter

Regulatory noticeRegulatory note (verified August 22, 2026): One sentence is all that FDA warning letter MARCS-CMS 715879 quotes. Sent to Sprout Health Partners LLC on September 9, 2025 after an August 2025 review of joinsprouthealth.com, it cites the line "GLP-1 medications are FDA-approved and backed by extensive clinical research..." Appearing on pages offering compounded semaglutide and tirzepatide, that statement implied to the agency that the compounded products themselves are FDA-approved, which they are not, and it was cited as misbranding under FD&C Act 502(a) and 502(bb). A search of FDA’s warning letter index turns up no close-out letter, so the matter appears open. Read the FDA letter

Regulatory noticeRegulatory note (verified August 22, 2026): Eden Health International Inc. was sent FDA warning letter MARCS-CMS 728279 on June 8, 2026, following an agency review of tryeden.com in March 2026. The letter lists two findings. The first is the "Eden" name on pictured labels for compounded semaglutide and tirzepatide, which the FDA said represents Eden as the compounder when it is not. The second is the site’s description of its sourcing as "FDA-licensed 503(a) outsourcing facilities," a designation the agency says does not exist, because the FD&C Act creates no FDA approval or license for pharmacies or outsourcing facilities. Both were cited as misbranding under sections 502(a) and 502(bb). FDA has posted no close-out letter, so the matter reads as open. Read the FDA letter

Verification limitationVerification note (checked August 23, 2026): we could not identify the legal entity behind HealthRx through public records. Its website does not name an operating company, its domain registration is privacy-shielded, and we could not confirm a listing in any business registry or accreditation database we checked. This is not a finding of wrongdoing. It means our usual checks, including our search of FDA enforcement records, could only be run against the brand name and domain rather than a confirmed company.

Regulatory noticeRegulatory note (verified August 22, 2026): Skinny.Rx operates as SkinnyRx, but the legal entity is Lean Rx, Inc., and that is the name on FDA warning letter MARCS-CMS 717989, dated February 20, 2026. Following a December 2025 review of skinnyrx.com, the agency objected to the "SkinnyRx" name on pictured labels, saying it implies SkinnyRx compounds the drugs itself, and to three marketing lines, including "Get access to the same active ingredient as name-brand GLP-1 medications" and "It contains the same active ingredient as FDA-approved medications." Compounded semaglutide and tirzepatide are not FDA-approved, so the FDA read those lines as implying an approval that does not exist and classed the products as misbranded. FDA's warning letter index carries no close-out letter for MARCS-CMS 717989, so read the matter as unresolved. Read the FDA letter

Regulatory noticeRegulatory note (verified August 22, 2026): Hers is a brand of Hims & Hers Health, Inc., and the FDA wrote to that company twice on September 9, 2025, once for each brand. The Hers letter, MARCS-CMS 716825, went to chief executive Andrew Dudum after an August 2025 review of forhers.com. It quotes two claims made for compounded semaglutide: "Weekly injectable GLP-1 with the same active ingredient as Ozempic and Wegovy" and "Clinically proven ingredients." The agency’s position is that compounded products carry no FDA approval, so claims like these imply a sameness with approved medicines that has not been established, making the products misbranded. FDA’s index lists neither a response nor a close-out letter, so the matter stands open. Read the FDA letter

Regulatory noticeRegulatory note (verified August 22, 2026): On September 9, 2025 the FDA sent Hims & Hers Health, Inc. a warning letter covering the Hims brand, MARCS-CMS 716567, drawn from a review of hims.com the previous month. Two lines about compounded semaglutide are quoted in it: "Same active ingredient as Ozempic and Wegovy" and "Clinically proven ingredients." Compounded drug products are not FDA-approved, and the agency said phrasing of this sort suggests otherwise, which is what makes the products misbranded under FD&C Act sections 502(a) and 502(bb). A companion letter went to the same company that day for its Hers brand. No close-out letter appears in FDA’s index; treat this as open. Read the FDA letter